16 november 2018
16 november 2018

Final results from T-Guard® Phase 1/2 trial in steroid-resistant aGVHD published in journal BBMT

Do you like it?
Read more
14 mei 2018
14 mei 2018

Dutch Company Xenikos Secures USD 30 Million in Series B Financing

Do you like it?
Read more
11 december 2017
11 december 2017

Data from phase 1/2 trial with T‑Guard® presented at ASH Annual Meeting

Do you like it?
Read more
Load more